Description
The National Cancer Institute (NCI) invites grant applications for exploratory research projects focused on the development and validation of emerging technologies for basic and clinical cancer research. The goal is to accelerate and enhance research in areas such as cancer biology, early detection, clinical diagnosis, treatment, and epidemiology. Applicants must propose technologies that offer novel capabilities for targeting, probing, analyzing, handling, or performing quality control of biospecimens used for cancer research. Key aspects of the job include:
• Developing and validating emerging technologies for cancer research
• Focusing on novel capabilities for biospecimen handling and analysis
• Enhancing research in areas such as cancer biology and clinical diagnosis
• Proposing technologies with potential for widespread applicability, but focused on cancer applications
• Ensuring projects are not applications of existing technologies where the novelty resides in the biological or clinical target/question being pursued.